Bond.az White LogoBond.az Black Logo

#leerink

Latest news and interesting information about leerink.

Today / 08:00
|
677

Leerink Reaffirms Eli Lilly Stock Rating on Gene Therapy

Leerink reaffirms Eli Lilly stock rating with Outperform and $1,119 target, citing promising gene therapy data from VERVE-102 trial. Bond.az covers the latest.

0
...